More recently, it has been shown that in human FcαR (CD89) transgenic mice, intranasal administration of a human IgA1 mAb specific for Acr1 combined with recombinant mouse IFN-γ significantly reduced bacterial load after intranasal Mtb-infection. Here, IFNG is linked to infection.